共 50 条
- [22] A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant chemotherapy followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in patients with resectable locally advanced gastric cancer: An interim efficacy report. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 408 - 408
- [29] Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer Cancer Chemotherapy and Pharmacology, 2014, 73 : 281 - 285